Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Orexigen Therapeutics revenue increased from $24.5 million in 2015 to $33.7 million in 2016, a (37.8%) increase.

Annual Revenue ($)

Orexigen Therapeutics revenue was $33.71 m in FY, 2016 which is a (37.8%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016
Revenue$4.4 m$3.43 m$3.43 m$55.52 m$24.46 m$33.71 m
Growth1,519.63%(55.95%)37.82%
Q2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017
Revenue$857 k$857 k$857 k$857 k$857 k$857 k$857 k$857 k$857 k$857 k$30.86 m$4.36 m$5.19 m$9.97 m$5.03 m$7.79 m$7 m$19.15 m$23.36 m$18.9 m

Annual Growth Rate (%)

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu